Karabudak R - Search Results

1

Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.

Karabudak R, Kurne A, Guc D, Sengelen M, Canpinar H, Kansu E. Karabudak R, et al. J Neurol. 2004 Mar;251(3):279-83. doi: 10.1007/s00415-004-0285-7. J Neurol. 2004. PMID: 15015006

2

Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.

Cohen M, Thomel-Rocchi O, Siva A, Okuda DT, Karabudak R, Efendi H, Terzi M, Carra-Dalliere C, Durand-Dubief F, Thouvenot E, Ciron J, Zephir H, Bourre B, Casez O, De Seze J, Moreau T, Neau JP, Pelletier D, Kantarci O, Tutuncu M, Derache N, Bensa C, Louapre C, Benoit J, Landes-Chateau C, Lebrun-Frenay C. Cohen M, et al. Among authors: karabudak r. Mult Scler. 2023 Aug;29(9):1099-1106. doi: 10.1177/13524585231179669. Epub 2023 Jun 15. Mult Scler. 2023. PMID: 37322880 Free PMC article.

3

Peripheral nervous system involvement in Behçet's disease. Case report and review of the literature.

Namer IJ, Karabudak R, Zileli T, Ruacan S, Küçükali T, Kansu E. Namer IJ, et al. Among authors: karabudak r. Eur Neurol. 1987;26(4):235-40. doi: 10.1159/000116342. Eur Neurol. 1987. PMID: 3595663

4

Familial Mediterranean fever and multiple sclerosis.

Topçuoğlu MA, Karabudak R. Topçuoğlu MA, et al. Among authors: karabudak r. J Neurol. 1997 Aug;244(8):510-4. doi: 10.1007/s004150050134. J Neurol. 1997. PMID: 9309558

5

Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity.

Bolay H, Karabudak R, Aybay C, Candemir H, Varli K, Imir T, Kansu E. Bolay H, et al. Among authors: karabudak r. J Neuroimmunol. 1998 Mar 1;82(2):109-15. doi: 10.1016/s0165-5728(97)00146-x. J Neuroimmunol. 1998. PMID: 9585806

6

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

Kantarci O, Siva A, Eraksoy M, Karabudak R, Sütlaş N, Ağaoğlu J, Turan F, Ozmenoğlu M, Toğrul E, Demirkiran M. Kantarci O, et al. Among authors: karabudak r. Neurology. 1998 Sep;51(3):765-72. doi: 10.1212/wnl.51.3.765. Neurology. 1998. PMID: 9748024

7

Multiphasic disseminated encephalomyelitis: a 4-year follow-up.

Unal I, Cigdem Dogulu F, Saygi S, Firat M, Ruacan S, Karabudak R. Unal I, et al. Among authors: karabudak r. Eur Neurol. 2000;43(1):55-8. doi: 10.1159/000008131. Eur Neurol. 2000. PMID: 10601811 No abstract available.

8

Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment.

Kilinc M, Saatci-Cekirge I, Karabudak R. Kilinc M, et al. Among authors: karabudak r. J Interferon Cytokine Res. 2003 Mar;23(3):127-33. doi: 10.1089/107999003321532457. J Interferon Cytokine Res. 2003. PMID: 12716484 Clinical Trial.

9

Karussis D, Biermann LD, Bohlega S, Boiko A, Chofflon M, Fazekas F, Freedman M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Miller A; International Working Group for Treatment Optimization in MS. Karussis D, et al. Among authors: karabudak r. Eur J Neurol. 2006 Jan;13(1):61-71. doi: 10.1111/j.1468-1331.2006.01147.x. Eur J Neurol. 2006. PMID: 16420394 Review.

10

Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of "AIDS-toxoplasmosis complex".

Ozkaya G, Kurne A, Unal S, Oğuz KK, Karabudak R, Saygi S. Ozkaya G, et al. Among authors: karabudak r. Epilepsy Behav. 2006 Aug;9(1):193-6. doi: 10.1016/j.yebeh.2006.04.005. Epub 2006 May 12. Epilepsy Behav. 2006. PMID: 16697709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters